[1]Rahier J.F., Magro F., Abreu C. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8:443-468.
[2]Cetkovska P., Lomicova I., Mukensnabl P., Kroes A.C. Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis. Dermatol Ther. 2015;28:369-372.
[3]Mizuta M., Schuster M.G. Cytomegalovirus hepatitis associated with use of anti-tumor necrosis factor-alpha antibody. Clin Infect Dis. 2005;40:1071-1072.
[4]Haag L.M., Hofmann J., Kredel L.I. Herpes Simplex Virus Sepsis in a Young Woman with Crohn's Disease. J Crohns Colitis. 2015;9:1169-1173.
[5]Meriglier E., Coudroy R., Agius G. Fatal fulminant varicella-zoster virus hepatitis in a female patient with Crohn's disease treated by an anti-TNF-alpha agent. Med Mal Infect. 2014;44:484-486.
[6]Donnelly M.C., Scobie L., Crossan C.L., Dalton H., Hayes P.C., Simpson K.J. Review article : hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther. 2017;46:126-141.
[7]Suzuki K., Kumagai I., Yoshida Y. Asymptomatic acute hepatitis E in a female patient with ulcerative colitis. Clin J Gastroenterol. 2017;10:255-260.
[8]Péron J.M., Abravanel F., Guillaume M. Treatment of autochthonous acute hepatitis E with short-term ribavirin : a multicenter retrospective study. Liver Int. 2016;36:328-333.
[9]Kamar N., Selves J., Mansuy J.M. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811-817.
[10]Kamar N., Rostaing L., Izopet J. Hepatitis E virus infection in immunosuppressed patients : natural history and therapy. Semin Liver Dis. 2013;33:62-70.
[11]Kamar N., Izopet J., Tripon S. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370:1111-1120.